common.study.topics.clinical

Assessing Medical Menstrual Regulation in the United States

common.study.values.description

Assessing Medical Menstrual Regulation in the United States

This study will assess the acceptability and use of medical menstrual regulation among women in the United States.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Mifepristone

All participants will receive 200 mg mifepristone, to be taken orally on day 1.

Drug - Misoprostol

All participants will receive 800 mcg misoprostol, to be taken buccally 24 hours after mifepristone (day 2)

participant.views.study.view.additional

participant.views.study.view.scientific-title

Assessing Acceptability and Use of Medical Menstrual Regulation in the United States

common.study.values.clinical-trial-id

NCT03972358

participant.views.study.view.id

e9rNJa